In addition, Apt-RAGE inhibited S100B-dependent activation of proliferation and migration of colorectal cancer cells, which are critical events for cancer cells to adapt to the TME during tumor progression (Figure 4(d)). This evidence concerns the gene LYPLA2P1 and colorectal cancer.